V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20195908 | 20152361 | 1.77 | 93.2 | Curative (C) | 2017-11-12 | 2017-11-27 | CETUXIMAB + IRINOTECAN + MDG | 02 | null | CAPECITABINE + GEMCITABINE | 100021206 |
| 20195911 | 20152362 | 1.85 | 71 | null | 2017-02-19 | 2017-03-08 | CETUXIMAB + IRINOTECAN + MDG | 02 | null | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101658253 |
| 20195914 | 20152363 | 1.55 | 60.3 | Palliative (P) | 2018-02-19 | 2018-03-06 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101721393 |
| 20195919 | 20152364 | 1.76 | 61.35 | null | 2016-10-17 | 2019-07-05 | Docetaxel 100mg/m2 (21 day) | 02 | null | DOCETAXEL | 101774608 |
| 20195920 | 20152365 | 1.66 | 83.2 | null | 2017-03-18 | 2017-05-02 | Docetaxel 75mg/m2 (21 day) | null | null | DOCETAXEL | 101478212 |
| 20195923 | 20152366 | 1.76 | 81.15 | null | 2020-02-12 | 2020-03-03 | Gemcitabine + Capecitabine | 02 | null | CAPECITABINE + GEMCITABINE | 101433427 |
| 20195926 | 20152367 | null | 64.4 | null | 2019-11-13 | 2019-11-15 | Gemcitabine + Capecitabine | 02 | null | CAPECITABINE + GEMCITABINE | 100427468 |
| 20195932 | 20152368 | 1.72 | 96 | null | 2017-03-24 | 2017-03-25 | CETUXIMAB + IRINOTECAN + MDG | 02 | null | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101351219 |
| 20195934 | 20152369 | 1.61 | 150.2 | Palliative (P) | 2019-10-14 | 2020-03-08 | Docetaxel | 02 | N | DOCETAXEL | 101868176 |
| 20195936 | 20152370 | 1.78 | 78.8 | Palliative (P) | 2018-10-23 | 2018-11-11 | Docetaxel | 02 | N | DOCETAXEL | 101843870 |
| 20195945 | 20152371 | 0 | 74.8 | null | 2017-06-13 | 2017-12-18 | CETUXIMAB + IRINOTECAN + MDG | 02 | null | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100736236 |
| 20195967 | 20152372 | 1.81 | 81.9 | null | null | 2018-05-25 | Docetaxel | 02 | null | DOCETAXEL | 101475914 |
| 20195969 | 20152373 | 1.47 | 72.6 | Neo-adjuvant (N) | 2016-09-16 | 2016-09-22 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101241730 |
| 20195970 | 20152374 | 1.6 | 66 | Palliative (P) | 2016-07-26 | 2016-07-30 | Cetuximab + FOLFIRI cycle1 | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100405644 |
| 20195974 | 20152375 | 1.83 | 62 | Adjuvant (A) | 2018-02-19 | 2018-02-24 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100771981 |
| 20195975 | 20152376 | 1.76 | 79.2 | Neo-adjuvant (N) | null | 2020-03-31 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 100422000 |
| 20195976 | 20152377 | 1.79 | 87 | null | 2014-02-04 | 2016-10-01 | Cetuximab + FOLFIRI cycle 2 onwards | 02 | null | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100615698 |
| 20195977 | 20152378 | 1.52 | 79.7 | Palliative (P) | 2016-05-02 | 2016-05-08 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101726030 |
| 20195981 | 20152379 | 1.72 | 96 | Palliative (P) | 2020-02-03 | 2020-02-16 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100763944 |
| 20195982 | 20152380 | 2 | 123 | null | 2018-03-30 | 2021-01-29 | Cetuximab + FLUOROURACIL + FOLINIC ACID + IRINOTECAN | 02 | null | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101764555 |
| 20195989 | 20152381 | 1.74 | 50 | Palliative (P) | 2019-08-22 | 2019-08-22 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101711618 |
| 20195993 | 20152382 | 1.7 | 67.55 | Palliative (P) | 2020-12-28 | 2020-12-29 | Docetaxel 75mg/m2 (21 day) | 02 | N | DOCETAXEL | 101861830 |
| 20195997 | 20152383 | 1.8 | 78 | null | 2017-02-03 | 2017-02-03 | CETUXIMAB + IRINOTECAN + MDG | 02 | null | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101382867 |
| 20195999 | 20152384 | 1.65 | 56 | Palliative (P) | null | 2017-11-11 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100423876 |
| 20196002 | 20152385 | 1.69 | 116 | Adjuvant (A) | 2017-11-11 | 2017-11-16 | Docetaxel | 02 | N | DOCETAXEL | 101628935 |
| 20196003 | 20152386 | 1.72 | 89.6 | null | 2018-07-27 | 2018-11-07 | Gemcitabine + Capecitabine | 02 | null | CAPECITABINE + GEMCITABINE | 100567560 |
| 20196008 | 20152387 | 1.57 | 98 | Palliative (P) | 2019-03-12 | 2019-04-02 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101152284 |
| 20196025 | 20152388 | 1.63 | 70 | Palliative (P) | 2019-04-23 | 2019-05-05 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100045643 |
| 20196026 | 20152389 | 1.63 | 90.3 | null | null | 2016-10-21 | CAPECITABINE + GEMCITABINE | null | null | CAPECITABINE + GEMCITABINE | 100122236 |
| 20196031 | 20152390 | 1.55 | 67.9 | Palliative (P) | 2020-01-12 | 2020-01-27 | Cetuximab + FOLFIRI cycle1 | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101086077 |
| 20196032 | 20152391 | 1.68 | 76 | Palliative (P) | 2017-10-12 | 2017-10-12 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | CAPECITABINE + GEMCITABINE | 101493710 |
| 20196033 | 20152392 | 1.84 | 45.05 | Neo-adjuvant (N) | 2018-10-17 | 2018-11-09 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 101281037 |
| 20196034 | 20152393 | 1.56 | 56.8 | Palliative (P) | 2018-03-18 | 2019-01-28 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101473764 |
| 20196035 | 20152394 | 1.69 | 62 | Palliative (P) | 2017-09-02 | 2017-09-15 | Cetuximab + FOLFIRI cycle 2 onwards | 02 | N | DOCETAXEL | 101207308 |
| 20196037 | 20152395 | 1.84 | 51.6 | Palliative (P) | 2020-01-19 | 2020-02-26 | CETUXIMAB + IRINOTECAN + MDG | 02 | null | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100517554 |
| 20196038 | 20152396 | 1.75 | 75 | null | 2020-08-09 | 2020-08-14 | CETUXIMAB + IRINOTECAN + MDG | 02 | null | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100879334 |
| 20196042 | 20152397 | 1.9 | 87.2 | Palliative (P) | 2019-09-15 | 2019-09-28 | Cetuximab + FLUOROURACIL + IRINOTECAN | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100362173 |
| 20196043 | 20152398 | null | 75.6 | Palliative (P) | 2019-04-04 | 2019-04-04 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101652372 |
| 20196049 | 20152399 | 1.67 | 65.6 | Palliative (P) | 2017-05-05 | 2017-05-13 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101163416 |
| 20196052 | 20152400 | 1.59 | 63.2 | Palliative (P) | 2019-07-05 | 2019-07-26 | Gemcitabine + Capecitabine | null | N | CAPECITABINE + GEMCITABINE | 101222963 |
| 20196053 | 20152401 | 1.74 | 98.4 | null | 2019-05-28 | 2019-07-21 | Docetaxel 75mg/m2 (21 day) | 02 | null | DOCETAXEL | 100041751 |
| 20196065 | 20152402 | 1.8 | 78 | Palliative (P) | 2016-10-27 | 2016-11-22 | Docetaxel 75mg/m2 (21 day) | 02 | N | DOCETAXEL | 101143406 |
| 20196068 | 20152403 | 1.67 | 49.5 | Palliative (P) | 2016-11-29 | 2016-12-17 | Docetaxel 100mg/m2 (21 day) | 02 | N | DOCETAXEL | 100971027 |
| 20196069 | 20152404 | 1.65 | 60.8 | Curative (C) | 2017-02-08 | 2017-06-04 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 100505413 |
| 20196073 | 20152405 | 1.69 | 71.7 | Palliative (P) | 2018-08-16 | 2018-09-01 | Cetuximab + FOLFIRI cycle1 | 02 | N | DOCETAXEL | 101109889 |
| 20196075 | 20152406 | 1.75 | 72.5 | Palliative (P) | 2018-09-13 | 2018-09-27 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 100642379 |
| 20196076 | 20152407 | 1.78 | 77.9 | null | 2017-03-28 | 2017-03-29 | Cetuximab + FOLFIRI cycle1 | N | null | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101831628 |
| 20196080 | 20152408 | 1.7 | 58.5 | Palliative (P) | 2018-10-16 | 2020-03-13 | Cetuximab + FOLFIRI cycle 2 onwards | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100276674 |
| 20196084 | 20152409 | 1.52 | 80.6 | Palliative (P) | 2016-05-08 | 2016-05-08 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100511933 |
| 20196091 | 20152410 | 1.65 | 93 | Palliative (P) | 2020-04-12 | 2020-04-12 | Cetuximab + FOLFIRI cycle 2 onwards | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100507443 |